MedTrace Logo

Change in Plaque Characteristics With Atorvastatin

NCT00700037 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2014-10-29

No results posted yet for this study

Summary

To examine effects of intensive lipid lowering therapy with atorvastatin on stabilization of coronary plaque by using optical coherence tomography (OCT) in patients with acute coronary syndrome.

Conditions

Interventions

DRUG

high-dose atorvastatin

20mg/day

DRUG

low-dose atorvastatin

5mg/day

Sponsors & Collaborators

  • Wakayama Medical University

    lead OTHER

Principal Investigators

  • Takashi Akasaka · Wakayama Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00700037 on ClinicalTrials.gov